Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View

Dr. Daniel Pollyea

Leukemia · CU Anschutz Medical Campus

View

Dr. Jessica Altman

Leukemia · Northwestern Medicine

View

Dr. Shella Saint Fleur-Lominy

Leukemia · UMSOM

View

Dr. Azra Raza

Leukemia · CUIMC

View

Dr. Molly Imgruet

Leukemia · Stanford

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    PSDr. Paramveer Singh

    Dr. Paramveer Singh

    Hematology & Oncology · Leukemia
    Roswell Park Comprehensive Cancer Center
    paramveer

    Research

    BiTE-secreting T cells rationally combine with PD-1 blockade and vaccine boosting to reshape antitumor immunity in ovarian cancer

    2026

    Via Mol Ther

    Research

    6-Phosphogluconate dehydrogenase promotes mitochondrial fusion and immune suppression in tumor-associated monocytic suppressor cells

    2026

    Via Nat Commun

    Research

    Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer

    2026

    Via Immunohorizons

    Research

    EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression

    2026

    Via Cancer Res

    Research

    Does the urinary microbiome reflect the bladder-cancer-associated microbiome? Characterizing the microbiome in urine and cancer tissue in bladder cancer

    2026

    Via Urol Oncol

    Research

    Nuclear-specific reductive carboxylation of alpha-ketoglutarate fuels histone acetylation to induce chromatin accessibility and gene activation

    2026

    Via Nat Commun

    Research

    Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance

    2026

    Via Cancer Immunol Res

    Research

    Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma

    2025

    Via Cancer Cell

    Research

    Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma

    2025

    Via Blood

    Research

    Targeting the pentose phosphate pathway mitigates graft-versus-host disease by rewiring alloreactive T cell metabolism

    2025

    Via JCI Insight

    Research

    Invasive Pulmonary Aspergillosis in Hospitalized Hematopoietic Stem Cell Transplantation Recipients: Outcomes Based on the United States National Readmission Database

    2023

    Via Hematology/Oncology and Stem Cell Therapy

    Research

    Emerging antibody therapies for pancreatic adenocarcinoma: a review of recent phase 2 trials

    2021

    Via Expert Opinion on Emerging Drugs

    Research

    Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents

    2021

    Via Leukemia & Lymphoma

    Research

    An HIV Associated Plasmablastic Lymphoma With Spontaneous Tumor Lysis Syndrome

    2020

    Via Cureus

    Research

    Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G-CSF or G-CSF and plerixafor mobilized grafts

    2019

    Via American Journal of Hematology